Humana ($HUM) senior management will meet investors Mar 2–31, 2026 and reaffirmed FY2026 guidance: GAAP…
Filed with the SEC on · Summarized by InvestorsBot
Humana ($HUM) senior management will meet investors Mar 2–31, 2026 and reaffirmed FY2026 guidance: GAAP diluted EPS ≥ $8.89; Adjusted (non‑GAAP) EPS ≥ $9.00. Guidance matches Feb 11 release. 📢 #EPS #Guidance #HealthCare
FY2026 reconciliation: GAAP $8.89 + amortization $0.15 − cumulative tax impact $0.04 = Adjusted EPS ≥ $9.00. Adjusted EPS is non‑GAAP, used for planning and incentive comp; company doesn’t expect changes to Adjusted guidance. 🧾 $HUM #NonGAAP #Investing
Humana ($HUM) cautions guidance is forward‑looking and GAAP EPS could change due to value‑creation/strategic initiatives. Investors should monitor upcoming disclosures from Mar meetings for any GAAP updates. 🔍 #HUM #Risk #Earnings